Enjoy complimentary customisation on priority with our Enterprise License!
The chemiluminescence immunoassay (CLIA) analyzers market share is expected to increase by USD 3.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 10.32%.
This chemiluminescence immunoassay analyzers market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by end-user (hospitals, clinical laboratories, PBC, and others) and geography (North America, Europe, Asia, and ROW). The chemiluminescence immunoassay analyzers market report also offers information on several market vendors, including Abbott Laboratories, Beckman Coulter Inc., Chengdu Seamaty Technology Co. Ltd., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Shenzhen New Industries Biomedical Engineering Co. Ltd., Siemens AG, Sysmex Corp., and Tosoh Corp. among others.
Download the Free Report Sample to Unlock the Chemiluminescence Immunoassay Analyzers Market Size for the Forecast Period and Other Important Statistics
The higher sensitivity and accuracy of CLA over ELISA is notably driving the CLIA analyzers market growth, although factors such as lack of trained professionals may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the chemiluminescence immunoassay analyzers industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
This chemiluminescence immunoassay analyzers market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the chemiluminescence immunoassay analyzers market encompasses successful business strategies deployed by the key vendors. The CLIA analyzers market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The chemiluminescence immunoassay analyzers market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
35% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for chemiluminescence immunoassay analyzers in North America. However, the market growth rate in North America will be slower than the growth of the market in other regions.
The fast-growing elderly population and the high prevalence of chronic and infectious diseases will facilitate the chemiluminescence immunoassay analyzers market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain further insights on the market contribution of various segments Request for a FREE sample
The chemiluminescence immunoassay analyzers market share growth by the hospitals segment will be significant during the forecast period. Chemiluminescence immunoassay (CLIA) analyzers are used in hospitals to perform a variety of tests, including those targeting autoimmune disorders, diabetes, thyroid, hepatitis, human immunodeficiency virus (HIV), and therapeutic drug monitoring.
This report provides an accurate prediction of the contribution of all the segments to the growth of the CLIA analyzers market size and actionable market insights on post COVID-19 impact on each segment.
Chemiluminescence Immunoassay Analyzers Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 10.32% |
Market growth 2022-2026 |
$ 3.24 billion |
Market structure |
Fragmented |
YoY growth (%) |
9.38 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 35% |
Key consumer countries |
US, UK, Canada, Germany, and France |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, Beckman Coulter Inc., Chengdu Seamaty Technology Co. Ltd., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Shenzhen New Industries Biomedical Engineering Co. Ltd., Siemens AG, Sysmex Corp., and Tosoh Corp. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.